These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31676442)
41. Characterization of binding interactions of (-)-epigallocatechin-3-gallate from green tea and lipase. Wu X; He W; Yao L; Zhang H; Liu Z; Wang W; Ye Y; Cao J J Agric Food Chem; 2013 Sep; 61(37):8829-35. PubMed ID: 23971865 [TBL] [Abstract][Full Text] [Related]
42. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Mattijssen F; Alex S; Swarts HJ; Groen AK; van Schothorst EM; Kersten S Mol Metab; 2014 Apr; 3(2):135-44. PubMed ID: 24634819 [TBL] [Abstract][Full Text] [Related]
43. Determination of lipoprotein lipase activity using a novel fluorescent lipase assay. Basu D; Manjur J; Jin W J Lipid Res; 2011 Apr; 52(4):826-32. PubMed ID: 21270098 [TBL] [Abstract][Full Text] [Related]
44. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640 [TBL] [Abstract][Full Text] [Related]
45. Computational approaches for the discovery of natural pancreatic lipase inhibitors as antiobesity agents. Almasri IM Future Med Chem; 2020 Apr; 12(8):741-757. PubMed ID: 32212943 [TBL] [Abstract][Full Text] [Related]
46. Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics. Sukhdev S; Bhupender S; Singh KS Mini Rev Med Chem; 2017; 17(4):371-379. PubMed ID: 27468785 [TBL] [Abstract][Full Text] [Related]
47. Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease? Olshan DS; Rader DJ J Clin Lipidol; 2018; 12(3):583-587. PubMed ID: 29548670 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Carrière F; Renou C; Ransac S; Lopez V; De Caro J; Ferrato F; De Caro A; Fleury A; Sanwald-Ducray P; Lengsfeld H; Beglinger C; Hadvary P; Verger R; Laugier R Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G16-28. PubMed ID: 11408251 [TBL] [Abstract][Full Text] [Related]
49. Cetilistat, a new lipase inhibitor for the treatment of obesity. Padwal R Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108 [TBL] [Abstract][Full Text] [Related]
50. Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition. Sangwai M; Sardar S; Vavia P Pharm Dev Technol; 2014 Feb; 19(1):31-41. PubMed ID: 23259606 [TBL] [Abstract][Full Text] [Related]
51. Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity. Vienberg SG; Kleinridders A; Suzuki R; Kahn CR Mol Metab; 2015 Feb; 4(2):144-50. PubMed ID: 25685701 [TBL] [Abstract][Full Text] [Related]
52. Carboxyl Ester Lipase May Not Mediate Lipotoxic Injury during Severe Acute Pancreatitis. Khatua B; Trivedi RN; Noel P; Patel K; Singh R; de Oliveira C; Trivedi S; Mishra V; Lowe M; Singh VP Am J Pathol; 2019 Jun; 189(6):1226-1240. PubMed ID: 30954473 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of lipases from Chromobacterium viscosum and Rhizopus oryzae by tetrahydrolipstatin. Potthoff AP; Haalck L; Spener F Biochim Biophys Acta; 1998 Jan; 1389(2):123-31. PubMed ID: 9461253 [TBL] [Abstract][Full Text] [Related]
54. Lipases and lipolysis in the human digestive tract: where do we stand? Armand M Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):156-64. PubMed ID: 17285003 [TBL] [Abstract][Full Text] [Related]
55. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity. Joyce P; Dening TJ; Meola TR; Gustafsson H; Kovalainen M; Prestidge CA Eur J Pharm Sci; 2019 Jul; 135():1-11. PubMed ID: 31067495 [TBL] [Abstract][Full Text] [Related]
56. The beta 5' loop of the pancreatic lipase C2-like domain plays a critical role in the lipase-lipid interactions. Chahinian H; Bezzine S; Ferrato F; Ivanova MG; Perez B; Lowe ME; Carrière F Biochemistry; 2002 Nov; 41(46):13725-35. PubMed ID: 12427035 [TBL] [Abstract][Full Text] [Related]
57. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss. Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247 [TBL] [Abstract][Full Text] [Related]
58. Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers. Shepard TY; Jensen DR; Blotner S; Zhi J; Guerciolini R; Pace D; Eckel RH Int J Obes Relat Metab Disord; 2000 Feb; 24(2):187-94. PubMed ID: 10702769 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Hadváry P; Lengsfeld H; Wolfer H Biochem J; 1988 Dec; 256(2):357-61. PubMed ID: 3223916 [TBL] [Abstract][Full Text] [Related]
60. Assignment of human pancreatic lipase gene (PNLIP) to chromosome 10q24-q26. Davis RC; Diep A; Hunziker W; Klisak I; Mohandas T; Schotz MC; Sparkes RS; Lusis AJ Genomics; 1991 Dec; 11(4):1164-6. PubMed ID: 1783385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]